Lenovo GOAST 4.0 Accelerates Genome Analysis to Just 24 Minutes

Lenovo has unveiled its latest advancement in genomic technology, the GOAST v4.0, a high-performance computing solution that significantly reduces the time needed for genome analysis to just 24 minutes. This breakthrough, announced on September 19, 2025, at a press event in Manila, Philippines, marks a significant leap forward in genomic sequencing, allowing researchers and healthcare professionals to decode complex genetic information at unprecedented speeds.

Since its inception in 2020, the GOAST platform has been instrumental in various fields, including pharmaceuticals, healthcare, agriculture, and drug discovery. With the latest update, a single node of GOAST v4.0 can process approximately 22,000 genomes annually, nearly tripling the throughput of previous versions. This enhancement empowers institutions to tackle the immense challenge of genomic data, with each human genome containing around 3 billion DNA base pairs, translating to trillions of cells needing analysis.

By compressing genome analysis from days to mere minutes, GOAST v4.0 facilitates advancements in precision medicine, cancer research, and national health initiatives. It achieves this while delivering GPU-level performance on optimized CPUs at costs up to 50% lower than traditional methods. Lenovo’s innovative approach includes a pay-as-you-go model through its High-Performance Computing-as-a-Service platform, TruScale, making advanced genomic capabilities accessible to organizations of all sizes.

Transforming Healthcare with Advanced Technology

According to Sumir Bhatia, President of Lenovo ISG Asia Pacific, “GOAST v4.0 breaks bioinformatics bottlenecks by combining Lenovo’s HPC expertise with genomics innovation.” He emphasized that this performance leap enables real-time discoveries that can save lives and promote global health equity.

The GOAST platform is already in operation at several leading research institutions worldwide. Notable users include the Council of Scientific and Industrial Research – Institute of Genomics & Integrative Biology (CSIR-IGIB) and the University of Delhi in India, as well as BRIN in Indonesia and Novo Genomics in Saudi Arabia. In addition, the Biobank of Thailand and a prominent children’s hospital in Australia are deploying GOAST to enhance their genomic research capabilities.

The growing adoption of GOAST in the Philippines highlights its potential in new markets, where local companies are investing in high-performance computing for applications in finance and weather forecasting. In India, multiple pharmaceutical firms are leveraging GOAST to optimize cancer research and accelerate drug discovery, illustrating the platform’s transformative impact across the healthcare ecosystem.

Beyond its contributions to genomics, GOAST v4.0 exemplifies the synergy of artificial intelligence and high-performance computing, driving innovations in algorithm design and bioinformatics workflows. This integration further solidifies GOAST’s role in the future of precision health.

Lenovo’s strategic advantage lies in its ability to unite healthcare experts, scientists, and researchers with its HPC hardware and software engineers. This collaboration fosters the development of multi-layered platforms like GOAST, which prioritize both speed and scientific depth to address some of humanity’s most pressing challenges.

As part of Lenovo’s vision for “Smarter AI for All,” GOAST v4.0 combines the best aspects of high-performance computing and artificial intelligence, making genomic research faster, more affordable, and accessible globally.

About Lenovo

Lenovo, a global technology leader with an annual revenue of USD 69 billion, ranks #196 in the Fortune Global 500, serving millions of customers across 180 markets worldwide. The company aims to deliver “Smarter Technology for All” and has expanded its offerings beyond PCs to include a full portfolio of AI-enabled devices, infrastructure, software, and services. Lenovo is committed to fostering world-changing innovations that contribute to a more equitable and intelligent future for all.

For more information, visit lenovo.com and explore the latest updates through their StoryHub.